secwatch.observer — SEC 8-K summary
======================================

Issuer:     INNOVATE Corp. (VATE)
CIK:        0001006837
Form:       8-K
Filed at:   2026-03-31T23:59:59+00:00
Accession:  0001006837-26-000019
Event type: regulatory
Sentiment:  positive
Materiality: 0.55
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

INNOVATE's MediBeacon receives CE Mark for TGFR Monitor and Reusable Sensor under EU MDR
--------------------------------------------------------------------------------

- MediBeacon (equity method investment of INNOVATE) obtained EU CE Mark under MDR for TGFR Monitor and Reusable Sensor.
- Devices are Class IIa; TGFR System enables transdermal assessment of kidney function (tGFR).
- CE Mark allows potential use in European clinical trials; Lumitrace injection approved in U.S. and China.
- Dr. Lui Forni plans to include transdermal GFR in his clinical research in Europe later this year.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1006837/000100683726000019/0001006837-26-000019-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1006837/000100683726000019/hchc-20260331.htm
  HTML page:      https://secwatch.observer/filing/0001006837-26-000019

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer